VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 20 filers reported holding VASCULAR BIOGENICS LTD in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,352 | +2.9% | 21,900 | -2.6% | 0.00% | – |
| Q2 2023 | $5,200 | +38.2% | 22,491 | 0.0% | 0.00% | – |
| Q1 2023 | $3,764 | +25.5% | 22,491 | 0.0% | 0.00% | – |
| Q4 2022 | $3,000 | -25.0% | 22,491 | -5.1% | 0.00% | – |
| Q3 2022 | $4,000 | -93.3% | 23,691 | -36.1% | 0.00% | – |
| Q2 2022 | $60,000 | -11.8% | 37,079 | +0.8% | 0.00% | – |
| Q1 2022 | $68,000 | +38.8% | 36,797 | +49.2% | 0.00% | – |
| Q4 2021 | $49,000 | -2.0% | 24,664 | 0.0% | 0.00% | – |
| Q3 2021 | $50,000 | -13.8% | 24,664 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | -13.4% | 24,664 | -27.1% | 0.00% | – |
| Q1 2021 | $67,000 | -13.0% | 33,842 | -16.9% | 0.00% | – |
| Q4 2020 | $77,000 | +45.3% | 40,710 | -5.3% | 0.00% | – |
| Q3 2020 | $53,000 | -18.5% | 42,994 | -15.9% | 0.00% | – |
| Q2 2020 | $65,000 | -5.8% | 51,131 | -0.2% | 0.00% | – |
| Q1 2020 | $69,000 | – | 51,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $4,382,000 | 1.02% |
| Telemetry Investments, L.L.C. | 75,000 | $127,000 | 0.20% |
| Ikarian Capital, LLC | 830,747 | $1,404,000 | 0.18% |
| DLD Asset Management, LP | 550,000 | $930,000 | 0.06% |
| Phoenix Holdings Ltd. | 1,020,000 | $1,724,000 | 0.03% |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $27,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $135,000 | 0.00% |
| HBK Sorce Advisory LLC | 22,325 | $38,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 12,000 | $20,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,155 | $21,000 | 0.00% |